RhinAV_Evaluation of Treatments for Acute Viral Rhinitis, Rhinosinusitis, and Rhinopharyngitis

Exclusion Criteria

• •Hypersensitivity/history of allergy to any of the product's components,
• •Complicated rhinitis, rhinosinusitis, or rhinopharyngitis (acute bacterial sinusitis, acute otitis media, acute bronchitis, or pneumonia) or severe cough that is poorly tolerated,
• •Chronic rhinosinusitis,
• •Allergic rhinosinusitis,
• •Other ongoing treatments for acute rhinitis (local treatment, antitussives, antibiotics, antiretrovirals, corticosteroids, etc.),
• •Positive antigen test for influenza A/B or COVID-19 and infection requiring etiological treatment according to the recommendations,
• •Bacterial rhinopharyngitis with positive TROD test
• •Comorbidities or health conditions deemed incompatible with the trial by the investigator,
• •Recent ENT surgery (\<6 months),
• •ENT pathology such as nasal septum deviation or other causes of nasal obstruction,
• •Pulmonary pathology (COPD, asthma, etc.),
• •Immunosuppression (as reported by the patient),
• •Pregnant or breastfeeding women,
• •Currently participating in another clinical trial, or in the exclusion period, or having received total compensation of more than €6,000 in the 12 months prior to the start of the trial,
• •Benefiting from legal protection measures (guardianship, trusteeship, deprivation of liberty, judicial protection).